PDF herunterladen
Thromb Haemost 1985; 53(02): 204-207
DOI: 10.1055/s-0038-1661274
Original Article
Schattauer GmbH Stuttgart

Agglutination of Platelet-Type von Willebrand’s Disease Platelets by Bovine von Willebrand Factor

Hoyu Takahashi
The First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
,
Akira Shibata
The First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 24. September 1984

Accepted 20. Dezember 1984

Publikationsdatum:
18. Juli 2018 (online)

 als PDF herunterladen  Lizenzen und Reprints

Summary

It has been shown that platelets from patients with platelet- type von Willebrand’s disease (vWD) agglutinate upon the addition of human von Willebrand factor (vWF) in the absence of ristocetin or botrocetin, suggesting that platelet membrane receptors for human vWF is abnormal. The present work reports the platelet agglutinability on stimulation with bovine vWF in platelet-type vWD. Platelets in patient platelet-rich plasma or washed platelet suspensions and patient platelets treated with formalin agglutinated in the presence of markedly lower concentrations of bovine vWF than those required for normal platelets. This finding provides additional evidence that platelet-type vWD platelets have abnormal expression of binding sites for vWF on their surface, and supports that platelet receptors for bovine vWF are identical or very close to those for human vWF.

Keywords

Platelet-type von Willebrand’s disease - von Willebrand factor - Bovine von Willebrand factor - Platelet agglutination - Receptor
 

  • References

  • 1 Takahashi H, Sakuragawa N, Shibata A. von Willebrand disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein. Am J Hematol 1980; 8: 299-308
    CrossrefPubMedSuche in Google Scholar
  • 2 Takahashi H. Studies on the pathophysiology and treatment of von Willebrand’s disease. IV Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand’s disease. Thromb Res 1980; 19: 857-867
    CrossrefPubMedSuche in Google Scholar
  • 3 Takahashi H, Nagayama R, Hattori A, Ihzumi T, Tsukada T, Shibata A. von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregation. Am J Hematol 1981 10: 80-99
    PubMed
  • 4 Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma J-P, Vicic WJ, Rogers J. Pseudo-von Willebrand’s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers N Engl J Med 1982; 306: 326-333
    CrossrefPubMedSuche in Google Scholar
  • 5 Miller JL, Castella A. Platelet-type von Willebrand’s disease: Characterization of a new bleeding disorder. Blood 1982; 60: 790-794
    PubMedSuche in Google Scholar
  • 6 Takahashi H, Handa M, Watanabe K, Ando Y, Nagayama R, Hattori A, Shibata A, Federici AB, Ruggeri ZM, Zimmermann TS. Further characterization of platelet-type von Willebrand’s disease in Japan. Blood 1984; 64: 1254-1262
    PubMedSuche in Google Scholar
  • 7 Miller JL, Kupinski JM, Castella A, Ruggeri ZM. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983; 72: 1532-1542
    CrossrefPubMedSuche in Google Scholar
  • 8 Takahashi H, Shibata A. Agglutination of formalin-fixed, platelet-type von Willebrand’s disease platelets by human von Willebrand factor. Thromb Haemostas 1984; 52: 267-270
    PubMedSuche in Google Scholar
  • 9 Takahashi H, Nagayama R, Hattori A, Shibata A. Botrocetin- and Polybrene-induced platelet aggregation in platelet-type von Willebrand disease. Am J Hematol. 1985 18. (in press)
    PubMedSuche in Google Scholar
  • 10 Forbes CD, Prentice CR M. Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature 1973; 241: 149-151
    CrossrefPubMedSuche in Google Scholar
  • 11 Griggs TR, Cooper HA, Webster WP, Wagner RH, Brinkhous KM. Plasma aggregating factor (bovine) for human platelets: A marker for study of anti-hemophilic and von Willebrand factors. Proc Natl Acad Sci USA 1973; 70: 2814-2818
    CrossrefPubMedSuche in Google Scholar
  • 12 Kirby EP, Mills DC B. The interaction of bovine factor VIII with human platelets. J Clin Invest 1975; 56: 491-502
    CrossrefPubMedSuche in Google Scholar
  • 13 Cooper HA, Clemetson KJ, Lüscher EF. Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): An integral membrane glycoprotein. Proc Natl Acad Sci USA 1979; 76: 1069-1073
    CrossrefPubMedSuche in Google Scholar
  • 14 Kao K-J, Pizzo SV, McKee PA. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. J Clin Invest 1979; 63: 656-664
    CrossrefPubMedSuche in Google Scholar
  • 15 Kao K-J, Pizzo SV, McKee PA. Platelet receptors for human factor VIII/von Willebrand factor protein: Functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. Proc Natl Acad Sci USA 1979; 76: 5317-5320
    CrossrefPubMedSuche in Google Scholar
  • 16 Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: An activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514-4518
    CrossrefPubMedSuche in Google Scholar
  • 17 Moake JL, Olson JD, Troll JH, Tang SS, Funicella T, Peterson DM. Binding of radioiodinated human von Willebrand factor to Bemard-Soulier, thrombasthenic and von Willebrand’s disease platelets. Thromb Res 1980; 19: 21-27
    CrossrefPubMedSuche in Google Scholar
  • 18 Nurden AT, Dupuis D, Kunicki TJ, Caen JP. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 1981; 67: 1431-1440
    CrossrefPubMedSuche in Google Scholar
  • 19 Okumura T, Jamieson GA. Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res 1976; 8: 701-706
    CrossrefPubMedSuche in Google Scholar
  • 20 Solum NO, Hagen I, Gjemdal T. Platelet membrane glycoproteins and the interaction between bovine factor VIII-related protein and human platelets. Thromb Haemostas 1977; 38: 914-923
    PubMedSuche in Google Scholar
  • 21 Solum NO, Hagen I, Peterka M, Gjemdal T. Absence of the 145000 molecular weight, soluble platelet membrane glycoprotein - Lack of platelet agglutination. Thromb Haemostas 1979; 42: 1626-1629
    PubMedSuche in Google Scholar
  • 22 Suzuki K, Nishioka J, Hashimoto S. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor. Thromb Res 1980; 17: 215-223
    CrossrefPubMedSuche in Google Scholar
  • 23 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
    PubMedSuche in Google Scholar
  • 24 Clemetson KJ. Platelet membrane glycoprotein I: Structure and function. The domain of glycoprotein I involved in the von Willebrand receptor Blood Cells 1983; 9: 319-329
    PubMedSuche in Google Scholar
  • 25 Born GV R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
    PubMedSuche in Google Scholar
  • 26 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedSuche in Google Scholar
  • 27 Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thrombos Diathes Haemorrh 1962; 7: 215-229
    PubMedSuche in Google Scholar
  • 28 Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thrombos Diathes Haemorrh 1975; 34: 306-308
    PubMedSuche in Google Scholar
  • 29 Holme S, Murphy S. Influence of platelet count and size on aggregation studies. J Lab Clin Med 1981; 97: 623-630
    PubMedSuche in Google Scholar
  • 30 Miller JL, Boselli BD, Kupinski JM. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand’s disease. Blood 1984; 63: 226-230
    PubMedSuche in Google Scholar